Literature DB >> 22652783

Role of miR-155 in breast cancer.

Jie Wang1, Jianhua Wu.   

Abstract

Breast cancer is the second leading cause of death due to cancer in women. Accumulating evidence shows a correlation between overexpression of miR-155 and breast cancer development. The microRNA (miRNA) encoded by mir-155 is known to be oncogenic in multiple tumors. This review summarizes the signaling pathways that are regulated by miR-155 in breast cancer and discusses therapeutic possibilities related to miR-155.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22652783     DOI： 10.2741/4056

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN： 2768-6698


  13 in total

Review 1.  Role of miR-155 in drug resistance of breast cancer.

Authors:  Dan-dan Yu; Meng-meng Lv; Wei-xian Chen; Shan-liang Zhong; Xiao-hui Zhang; Lin Chen; Teng-fei Ma; Jin-hai Tang; Jian-hua Zhao
Journal:  Tumour Biol       Date:  2015-03-06

2.  miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway.

Authors:  Xue Wu; Jun Li; Xuekang Yang; Xiaozhi Bai; Jihong Shi; Jianxin Gao; Yan Li; Shichao Han; Yijie Zhang; Fu Han; Yang Liu; Xiaoqiang Li; Kejia Wang; Julei Zhang; Zheng Wang; Ke Tao; Dahai Hu
Journal:  J Mol Histol       Date:  2018-05-21       Impact factor: 2.611

3.  Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer.

Authors:  Sinae Kim; Je-keun Rhee; Hyun Ju Yoo; Hee Jin Lee; Eun Ji Lee; Jong Won Lee; Jong Han Yu; Byung Ho Son; Gyungyup Gong; Sung Bae Kim; Shree Ram Singh; Sei Hyun Ahn; Suhwan Chang
Journal:  Cancer Lett       Date:  2014-12-04       Impact factor: 8.679

Review 4.  miRNAs and cancer: an epigenetics view.

Authors:  Marcos Malumbres
Journal:  Mol Aspects Med       Date:  2012-07-04

Review 5.  Therapeutic evaluation of microRNAs by molecular imaging.

Authors:  Thillai V Sekar; Ramkumar Kunga Mohanram; Kira Foygel; Ramasamy Paulmurugan
Journal:  Theranostics       Date:  2013-12-06       Impact factor: 11.556

Review 6.  Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Authors:  Roberto Gambari; Eleonora Brognara; Demetrios A Spandidos; Enrica Fabbri
Journal:  Int J Oncol       Date:  2016-05-04       Impact factor: 5.650

7.  MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.

Authors:  Jiansong Ji; Min Xu; Jianfei Tu; Zhongwei Zhao; Jun Gao; Minjiang Chen; Jingjing Song; Haidong Zhu; Xingyao Cheng; Junguo Hui; Xilin Lan; Xiaoming Yang
Journal:  Oncotarget       Date:  2016-09-13

8.  Serum microRNA-155 as a potential biomarker to track disease in breast cancer.

Authors:  Yu Sun; Minjie Wang; Guigao Lin; Shipeng Sun; Xuexiang Li; Jun Qi; Jinming Li
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

9.  MicroRNA expression profiles in avian haemopoietic cells.

Authors:  Yongxiu Yao; Jane Charlesworth; Venugopal Nair; Mick Watson
Journal:  Front Genet       Date:  2013-08-14       Impact factor: 4.599

10.  Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration.

Authors:  Sinae Kim; Jin Hoi Song; Seokho Kim; Peng Qu; Betty K Martin; Waheed S Sehareen; Diana C Haines; Pengnian C Lin; Shyam K Sharan; Suhwan Chang
Journal:  Oncotarget       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.